Association of the Spectrum of Cutaneous Lupus Erythematosus with Disease Activity and Systemic Manifestations in Patients with Systemic Lupus ErythematosusOriginal Paper Published on 2024-03-192024-09-04 Journal: Mediterranean Journal of Rheumatology [Category] 대상포진, [키워드] Cutaneous Lupus cutaneous manifestation Disease activity systemic lupus erythematosus [DOI] 10.31138/mjr.200423.aos PMC 바로가기 [Article Type] Original Paper
Serum IFNα2 levels are associated with disease activity and outperform IFN-I gene signature in a longitudinal childhood-onset SLE cohortBasic Science Published on 2023-08-142024-09-04 Journal: Rheumatology (Oxford, England) [Category] 대상포진, [키워드] Disease activity IFN signature Simoa SLE Type I IFN [DOI] 10.1093/rheumatology/keac698 PMC 바로가기 [Article Type] Basic Science
Primary SARS-CoV-2 infection in patients with immune-mediated inflammatory diseases: long-term humoral immune responses and effects on disease activityarticle Published on 2023-05-172024-09-05 Journal: BMC Infectious Diseases [Category] update2024, [키워드] antibodies Autoimmune disease COVID-19 Disease activity flare Immune-mediated inflammatory diseases Immunity Immunosuppression SARS-CoV-2 TNF [DOI] 10.1186/s12879-023-08298-6 PMC 바로가기 [Article Type] article
SARS-CoV-2 pandemic as a model to assess the relationship between intercurrent viral infections and disease activity in Multiple Sclerosis: A propensity score matched case-control studyArticle Published on 2023-04-102024-09-05 Journal: Multiple sclerosis and related disorders [Category] update2024, [키워드] COVID-19 Disease activity infections multiple sclerosis NEDA virus [DOI] 10.1016/j.msard.2023.104715 PMC 바로가기 [Article Type] Article
Low serum level of citrullinated histone H3 in patients with dermatomyositisResearch Article Published on 2023-04-012024-09-05 Journal: Journal of Clinical Laboratory Analysis [Category] update2024, [키워드] biochemical marker citrullinated histone H3 dermatomyositis Disease activity [DOI] 10.1002/jcla.24876 PMC 바로가기 [Article Type] Research Article
Comprehensive evaluation of the influence of sex differences on composite disease activity indices for rheumatoid arthritis: results from a nationwide observational cohort studyarticle Published on 2023-03-212024-09-02 Journal: BMC Rheumatology [Category] 대상포진, [키워드] CDAI CRP DAS28 Disease activity ESR rheumatoid arthritis SDAI Sex difference [DOI] 10.1186/s41927-023-00328-9 PMC 바로가기 [Article Type] article
Effects of SARS-CoV-2 vaccine (Vero cells) on disease activity in patients with inflammatory bowel disease in China: a multicenter studyResearch Published on 2023-02-092024-09-05 Journal: International journal of colorectal disease [Category] update2024, [키워드] Crohn’s disease Disease activity inflammatory bowel diseases SARS-CoV-2 vaccination ulcerative colitis [DOI] 10.1007/s00384-023-04315-x PMC 바로가기 [Article Type] Research
Disease activity in patients with immune-mediated inflammatory diseases after SARS-CoV-2 vaccinationsArticle Published on 2023-01-022024-09-05 Journal: Journal of autoimmunity [Category] update2024, [키워드] Autoimmune disease COVID-19 Disease activity flare SARS-CoV-2 vaccination [DOI] 10.1016/j.jaut.2022.102984 PMC 바로가기 [Article Type] Article
Continuous effectiveness and safety after a hospital‐wide switch to adalimumab biosimilar: An observational study in rheumatoid arthritis patientsOriginal Article Published on 2022-12-082024-09-04 Journal: Pharmacology Research & Perspectives [Category] 대상포진, [키워드] adalimumab biological therapies Biosimilar Disease activity rheumatoid arthritis switch [DOI] 10.1002/prp2.1025 PMC 바로가기 [Article Type] Original Article
Managing ANCA-associated vasculitis during COVID-19 pandemic: a single-center cross-sectional studyArticle Published on 2022-12-012022-11-15 Journal: Rheumatology International [Category] 바이오마커, 진단, [키워드] Active disease ANCA-associated vasculitis Care clinical manifestations Cohort conducted COVID-19 COVID-19 infection COVID-19 severity Critical cross-sectional Cyclophosphamide death demographic died Disease activity Features Follow-up General population Immunosuppressant increased risk India Infection managing moderate non-COVID-19 patient not differ ocular outcome Patient patients patients died predicted receiving regimen required risk of COVID-19 rituximab SARS-CoV-2 severity single-center Supplemental oxygen therapy the patient Treatment Univariate analysis Vasculitis [DOI] 10.1007/s00296-022-05177-2 PMC 바로가기